Alberta Diabetes Institute

Edmonton, Alberta T6G 2E1

2 studies enrolling now · 10 studies all time

What they study most

Coronary Artery Disease, Diabetes Mellitus, Diabetes Mellitus Type 1, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Gastroparesis, Heart Failure, Hyperphagia in Prader-Willi Syndrome, Kidney Failure, Chronic, Obesity, Overweight

Studies at this site

• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease — Recruiting now
• A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes — Running, not enrolling
• A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities — Running, not enrolling
• Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) — Running, not enrolling
• OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome — Enrolling by invitation
• Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome — Running, not enrolling
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 — Stopped early
• Diabetic Gastroparesis Study 05 — Stopped early
• Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 — Stopped early
• A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes — Completed